* LifeMD Inc LFMD.OQ LFMD.O is expected to show a rise
in
quarterly revenue when it reports results on March 6
(estimated).
* The New York City-based company is expected to report a
22.6% increase in revenue to $33.6 million from $27.42 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for LifeMD Inc is for a
loss
of 18 cents per share.
* The one available analyst rating on the shares is "strong
buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for LifeMD Inc
is
$8, above its last closing price of $1.79.
This summary was machine generated March 3 at 11:31 GMT. All
figures in US dollars unless otherwise stated